Skip to content
2000
Volume 7, Issue 2
  • ISSN: 1574-888X
  • E-ISSN: 2212-3946

Abstract

Tissue engineering of bone has the potential to overcome the limitations of using autologous, allogeneic or synthetic bone grafts to treat extensive bone defects. It involves culturing of osteogenic cells within appropriate scaffold materials under conditions that optimize bone development. Stem cells, progenitor cells, terminally differentiated cells or genetically modified cells may be used. Scaffold materials include polymers, ceramics or composites which are used to maintain the desirable characteristics of the individual materials. Preclinical and clinical studies on the use of growth factors such as bone morphogenetic proteins to increase bone formation have had promising results. This review discusses the approaches to and the challenges associated with producing tissue engineered bone.

Loading

Article metrics loading...

/content/journals/cscr/10.2174/157488812799219036
2012-03-01
2025-10-05
Loading full text...

Full text loading...

/content/journals/cscr/10.2174/157488812799219036
Loading
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test